Invivyd (IVVD) Amortization of Deferred Charges (2022 - 2025)
Invivyd (IVVD) posted Amortization of Deferred Charges of $286000.0 for Q4 2025, up 1.42% on a QoQ basis from $282000.0 in Q3 2025, and down 33.8% year-over-year from $432000.0 in Q4 2024.
Invivyd (IVVD) Amortization of Deferred Charges (2022 - 2025) Analysis & Trends
Invivyd's Amortization of Deferred Charges history runs 4 years deep, the most recent figure standing at $286000.0 for Q4 2025.
- Quarterly Amortization of Deferred Charges fell 33.8% year-over-year to $286000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (down 17.91% YoY) and the FY2025 annual result came in at $1.4 million, down 17.91% from the prior year.
- Amortization of Deferred Charges was $286000.0 for Q4 2025 at Invivyd, up from $282000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $432000.0 in Q4 2024 and bottomed at $31000.0 in Q3 2022.
- A 4-year average of $310500.0 and a median of $381500.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges jumped 1154.84% — and 2025, when it plunged 33.96%.
- Invivyd's Amortization of Deferred Charges stood at $179000.0 in 2022, then jumped by 121.23% to $396000.0 in 2023, then gained by 9.09% to $432000.0 in 2024, then sank by 33.8% to $286000.0 in 2025.
- Business Quant data shows IVVD's Amortization of Deferred Charges at $286000.0 in Q4 2025, $282000.0 in Q3 2025, and $352000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - |
| 10 | Invivyd | 107.29 Mn | -119.40 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 286,000.00 |
| Dec 31, 2025 | 286,000.00 |
| Sep 30, 2025 | 282,000.00 |
| Sep 30, 2025 | 282,000.00 |
| Jun 30, 2025 | 352,000.00 |
| Jun 30, 2025 | 352,000.00 |
| Mar 31, 2025 | 432,000.00 |
| Mar 31, 2025 | 432,000.00 |
| Dec 31, 2024 | 432,000.00 |
| Dec 31, 2024 | 432,000.00 |
| Sep 30, 2024 | 427,000.00 |
| Sep 30, 2024 | 427,000.00 |
| Jun 30, 2024 | 386,000.00 |
| Jun 30, 2024 | 386,000.00 |
| Mar 31, 2024 | 402,000.00 |
| Mar 31, 2024 | 402,000.00 |
| Dec 31, 2023 | 396,000.00 |
| Dec 31, 2023 | 396,000.00 |
| Sep 30, 2023 | 389,000.00 |
| Sep 30, 2023 | 389,000.00 |